Conlin, Paul R;
Burke, Brian V;
Hobbs, Curtis;
Hurren, Kathryn M;
Lang, Adam Edward;
Morrison, John W;
Spacek, Lance;
Steil, Evan N;
Watts, Sharon A;
Weinreb, Jane E;
Pogach, Leonard M.
The US Department of Veterans Affairs (VA) and the US Department of Defense (DoD) approved a joint clinical practice guideline for the management of type 2 diabetes. This was the product of a multidisciplinary guideline development committee composed of clinicians from both the VA and the DoD and was ove...
The American College of Physicians (ACP) developed this clinical guideline to update recommendations on newer pharmacologic treatments of type 2 diabetes. This clinical guideline is based on the best available evidence for effectiveness, comparative benefits and harms, consideration of patients’ values...
The previous treatment guide for type 2 diabetes was prepared by the Estonian Society of Endocrinology
led in 2016 and discussed type 2 diabetes screening, diagnosis and
pharmacological treatment (1). The guideline was prepared as an expert opinion/consensus and no
followed the agreed methodology, which ...
Clinical question What are the benefits and harms of sodium-glucose cotransporter 2 (SGLT-2) inhibitors and glucagon-like peptide 1 (GLP-1) receptor agonists when added to usual care (lifestyle interventions and/or other diabetes drugs) in adults with type 2 diabetes at different risk for cardiovascular ...
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications. In December 2020, we made minor changes to the ...
Diabetes Mellitus, Type 2/drug therapy,
Diabetes Mellitus, Type 2/prevention & control,
Patient Education as Topic,
Glucose/analysis,
Eye-Tracking Technology,
Dipeptidyl-Peptidase IV Inhibitors/therapeutic use,
Pioglitazone/therapeutic use,
Sulfonylurea Compounds/therapeutic use,
Platelet Aggregation Inhibitors/therapeutic use
DESCRIPTION: In April 2017, the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of type 2 diabetes mellitus. METHODS: The VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline developme...
Diabetes Mellitus, Type 2/drug therapy,
Hypoglycemic Agents/administration & dosage,
Glycemic Index,
Clinical Decision-Making,
Patient-Centered Care,
Biomarkers/blood,
Diabetes Mellitus, Type 2/blood,
Life Expectancy,
Fructosamine/blood,
Glycated Hemoglobin/analysis
This guideline covers how to identify adults at high risk of type 2 diabetes. It aims to remind practitioners that age is no barrier to being at high risk of, or developing, the condition. It also aims to help them provide those at high risk with an effective and appropriate intensive lifestyle-change pr...
DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on oral pharmacologic treatment of type 2 diabetes in adults. This guideline serves as an update to the 2012 ACP guideline on the same topic. This guideline is endor...
Diabetes Mellitus, Type 2/drug therapy,
Arterial Pressure/drug effects,
Diabetic Angiopathies/prevention & control,
Glycated Hemoglobin,
Heart Rate/drug effects,
Hypoglycemic Agents/administration & dosage,
Metformin/administration & dosage,
Sulfonylurea Receptors/administration & dosage,
Weight Loss,
Drug Therapy, Combination
Entregar recomendaciones para apoyar a los equipos de salud en la toma de decisiones clínicas respecto del tratamiento farmacológico en pacientes adultos con diagnóstico de Diabetes Mellitus tipo
2, basadas en la mejor evidencia científica disponible y el consenso de expertos....
"OBJECTIVE:
To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes.
PARTICIPANTS:
The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical write...
Blood Glucose,
Combined Modality Therapy,
Diabetes Mellitus, Type 1,
Diabetes Mellitus, Type 2,
Diet, Diabetic,
Drug Monitoring,
Endocrinology,
Hyperglycemia,
Hypoglycemia,
Insulin/therapeutic use,
Insulin Infusion Systems,
Monitoring, Ambulatory,
Patient Education as Topic,
Precision Medicine,
Diabetes Mellitus, Type 1/drug therapy,
Diabetes Mellitus, Type 2/drug therapy,
Diabetes Mellitus, Type 1/therapy,
Diabetes Mellitus, Type 2/therapy,
Hypoglycemic Agents/therapeutic use,
Hypoglycemic Agents/adverse effects,
Insulin/adverse effects
